Autolus Therapeutics plc is a startup based in London, the United Kingdom, 2 tracked investors.
Autolus Therapeutics plc is a company headquartered in London, the United Kingdom. Brouky records 2 investors associated with the company.
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company developing programmed T-cell therapies, including CAR-T cell therapies, for the treatment of cancer. The company engineers and programs T cells to target hematologic and solid tumor malignancies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.